Basir MB, Kapur NK, Patel K, Salam MA, Schreiber T, Kaki A, Hanson I, Almany S, Timmis S, Dixon S, Kolski B, Todd J, Senter S, Marso S, Lasorda D, Wilkins C, Lalonde T, Attallah A, Larkin T, Dupont A, Marshall J, Patel N, Overly T, Green M, Tehrani B, Truesdell AG, Sharma R, Akhtar Y, McRae T, O’Neill B, Finley RA, Foster M, Askari R, Goldsweig A, Martin S, Bharadwaj A, Khuddus M, Caputo C, Korpas D, Cawich I, McAllister D, Blank N, Alraies MC, Fisher R, Khandelwal A, Alaswad K, Lemor A, Johnson T, Hacala M, O’Neill WW, Investigators NCSI (2019) Improved outcomes associated with the use of shock protocols: updates from the national cardiogenic shock initiative. Catheterization Cardiovasc Interv 93(7):1173–1183
Kasahara T, Sakakura K, Hori N, Jinnouchi H, Taniguchi Y, Tsukui T, Watanabe Y, Yamamoto K, Seguchi M, Wada H, Fujita H (2023) Comparison of in-hospital outcomes of acute myocardial infarction between patients with cardiogenic shock and with cardiac arrest. Heart Vessel 38(2):139–146
Møller JE, Engstrøm T, Jensen LO, Eiskjær H, Mangner N, Polzin A, Schulze PC, Skurk C, Nordbeck P, Clemmensen P, Panoulas V, Zimmer S, Schäfer A, Werner N, Frydland M, Holmvang L, Kjærgaard J, Sørensen R, Lønborg J, Lindholm MG, Udesen NLJ, Junker A, Schmidt H, Terkelsen CJ, Christensen S, Christiansen EH, Linke A, Woitek FJ, Westenfeld R, Möbius-Winkler S, Wachtell K, Ravn HB, Lassen JF, Boesgaard S, Gerke O, Hassager C, Investigators DS (2024) Microaxial flow pump or standard care in infarct-related cardiogenic shock. N Engl J Med 390(15):1382–1393
Ikeda Y, Ishii S, Maemura K, Oki T, Yazaki M, Fujita T, Iida Y, Kinoshita D, Sato N, Ako J (2022) Hemodynamic assessment and risk classification for successful weaning of Impella in patients with cardiogenic shock. Artif Organ 46(7):1358–1368
Pocock SJ, Wang D, Pfeffer MA, Yusuf S, McMurray JJ, Swedberg KB, Ostergren J, Michelson EL, Pieper KS, Granger CB (2006) Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J 27(1):65–75
Fox K, Ford I, Steg G, Tendera M, Robertson M, Ferrari R (2008) Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial. Lancet 372:817–821
Böhm M, Swedberg K, Komajda M, Borer JS, Ford I, Dubost-Brama A, Lerebours G, Tavazzi L, Investigators SHIFT (2010) Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial. Lancet 376:886–894
Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, Buller CE, Jacobs AK, Slater JN, Col J, McKinlay SM, LeJemtel TH (1999) Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. N Engl J Med 341(9):625–634
Article CAS PubMed Google Scholar
Fincke R, Hochman JS, Lowe AM, Menon V, Slater JN, Webb JG, LeJemtel TH, Cotter G, Investigators SHOCK (2004) Cardiac power is the strongest hemodynamic correlate of mortality in cardiogenic shock: a report from the SHOCK trial registry. J Am Coll Cardiol 44(2):340–348
Lim HS, Gustafsson F (2020) Pulmonary artery pulsatility index: physiological basis and clinical application. Eur J Heart Fail 22(1):32–38
Wernovsky G, Wypij D, Jonas RA, Mayer JE Jr, Hanley FL, Hickey PR, Walsh AZ, Chang AC, Castañeda AR, Newburger JW, Wessel DL (1995) Postoperative course and hemodynamic profile after the arterial switch operation in neonates and infants. Circulation 92(8):2226–2235
Article CAS PubMed Google Scholar
Gaies MG, Gurney JG, Yen AH, Napoli ML, Gajarski RJ, Ohye RG, Charpie JR, Hirsch JC (2010) Vasoactive–inotropic score as a predictor of morbidity and mortality in infants after cardiopulmonary bypass. Pediatr Crit Care Med 11(2):234–238
Düngen HD, Apostolovic S, Inkrot S, Tahirovic E, Töpper A, Mehrhof F, Prettin C, Putnikovic B, Neskovic AN, Krotin M, Sakac D, Lainscak M, Edelmann F, Wachter R, Rau T, Eschenhagen T, Doehner W, Anker SD, Waagstein F, Herrmann-Lingen C, Gelbrich G, Dietz R; CIBIS-ELD investigators and Project Multicentre Trials in the Competence Network Heart Failure (2011) Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure : the CIBIS-ELD trial. Eur J Heart Fail 13(6):670–680
Jentzer JC, van Diepen S, Barsness GW, Henry TD, Menon V, Rihal CS, Naidu SS, Baran DA (2019) Cardiogenic shock classification to predict mortality in the cardiac intensive care unit. J Am Coll Cardiol 74(17):2117–2128
Kindermann M, Schwaab B, Finkler N, Schaller S, Böhm M, Fröhlig G (2002) Defining the optimum upper heart rate limit during exercise: a study in pacemaker patients with heart failure. Eur Heart J 23(16):1301–1308
Article CAS PubMed Google Scholar
Abraham WT, Adams KF, Fonarow GC, Costanzo MR, Berkowitz RL, LeJemtel TH, Cheng ML, Wynne J; ADHERE Scientific Advisory Committee and Investigators; ADHERE Study Group (2005) In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the acute decompensated heart failure national registry (ADHERE). J Am Coll Cardiol 46(1):57–64
Bloom JE, Chan W, Kaye DM, Stub D (2023) State of shock: contemporary vasopressor and inotrope use in cardiogenic shock. J Am Heart Assoc 12(15):e029787
Article CAS PubMed Central PubMed Google Scholar
Jentzer JC, Lawler PR, van Diepen S, Henry TD, Menon V, Baran DA, Džavík V, Barsness GW, Holmes DR Jr, Kashani KB (2020) Systemic inflammatory response syndrome is associated with increased mortality across the spectrum of shock severity in cardiac intensive care patients. Circ Cardiovasc Qual Outcomes 13(12):e006956
Schrage B, Ibrahim K, Loehn T, Werner N, Sinning JM, Pappalardo F, Pieri M, Skurk C, Lauten A, Landmesser U, Westenfeld R, Horn P, Pauschinger M, Eckner D, Twerenbold R, Nordbeck P, Salinger T, Abel P, Empen K, Busch MC, Felix SB, Sieweke JT, Møller JE, Pareek N, Hill J, MacCarthy P, Bergmann MW, Henriques JPS, Möbius-Winkler S, Schulze PC, Ouarrak T, Zeymer U, Schneider S, Blankenberg S, Thiele H, Schäfer A, Westermann D (2019) Impella support for acute myocardial infarction complicated by cardiogenic shock: matched-pair iabp-shock II trial 30 day mortality analysis. Circulation 139(10):1249–1258
Mulder P, Barbier S, Chagraoui A, Richard V, Henry JP, Lallemand F, Renet S, Lerebours G, Mahlberg-Gaudin F, Thuillez C (2004) Long-term heart rate reduction induced by the selective if current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure. Circulation 109(13):1674–1679
Article CAS PubMed Google Scholar
Colin P, Ghaleh B, Monnet X, Hittinger L, Berdeaux A (2004) Effect of graded heart rate reduction with ivabradine on myocardial oxygen consumption and diastolic time in exercising dogs. J Pharmacol Exp Ther 308(1):236–240
Article CAS PubMed Google Scholar
Hasenfuss G, Holubarsch C, Hermann HP, Astheimer K, Pieske B, Just H (1994) Influence of the force-frequency relationship on haemodynamics and left ventricular function in patients with non-failing hearts and in patients with dilated cardiomyopathy. Eur Heart J 15(2):164–170
Article CAS PubMed Google Scholar
Kelly RP, Ting CT, Yang TM, Liu CP, Maughan WL, Chang MS, Kass DA (1992) Effective arterial elastance as index of arterial vascular load in humans. Circulation 86(2):513–521
Article CAS PubMed Google Scholar
Reil JC, Reil GH, Böhm M (2009) Heart rate reduction by if-channel inhibition and its potential role in heart failure with reduced and preserved ejection fraction. Trend Cardiovasc Med 19(5):152–157
Merlo M, Caiffa T, Gobbo M, Adamo L, Sinagra G (2018) Reverse remodeling in dilated cardiomyopathy: Insights and future perspectives. Int J Cardiol Heart Vasc 18:52–57
CAS PubMed Central PubMed Google Scholar
Flannery G, Gehrig-Mills R, Billah B, Krum H (2008) Analysis of randomized controlled trials on the effect of magnitude of heart rate reduction on clinical outcomes in patients with systolic chronic heart failure receiving beta-blockers. Am J Cardiol 101(6):865–869
Article CAS PubMed Google Scholar
Pfeffer MA, Braunwald E (1990) Ventricular remodeling after myocardial infarction: experimental observations and clinical implications. Circulation 81(4):1161–1172
Article CAS PubMed Google Scholar
Müller KD, Sass S, Gottwik MG, Schaper W (1982) Effect of myocardial oxygen consumption on infarct size in experimental coronary artery occlusion. Basic Res Cardiol 77(2):170–181
Saku K, Kakino T, Arimura T, Sakamoto T, Nishikawa T, Sakamoto K, Ikeda M, Kishi T, Ide T, Sunagawa K (2016) Total mechanical unloading minimizes metabolic demand of left ventricle and dramatically reduces infarct size in myocardial infarction. PLoS ONE 11(4):e0152911
Article PubMed Central PubMed Google Scholar
Chen Z, Xie J (2005) Early intravenous then oral metoprolol in 45852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 366(9497):1622–1632
Comments (0)